Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;79(4):354-369.
doi: 10.1590/0004-282X-ANP-2020-0432.

Cannabinoids in Neurology - Position paper from Scientific Departments from Brazilian Academy of Neurology

Sonia Maria Dozzi Brucki  1   2 Tarso Adoni  3   4 Carlos Mauricio Oliveira Almeida  5   6 Daniel Ciampi de Andrade  1 Renato Anghinah  1 Luciana Mendonça Barbosa  1 Rodrigo Bazan  7 Alzira Alves de Siqueira Carvalho  8 William Carvalho  9 Paulo Pereira Christo  10   11 Marcus Della Coletta  12 Adriana Bastos Conforto  1 Ylmar Correa-Neto  13 Eliasz Engelhardt  14 Marcondes Cavalcante França Junior  15 Clelia Franco  16 Felipe VON Glehn  17 Helio Rodrigues Gomes  1 Caroline Gomes de Barros Houly  18 Alexandre Ottoni Kaup  19 Fernando Kowacs  20   21 Aline Kanashiro  22 Victor Gonçalves Lopes  23 Débora Maia  11 Maria Manreza  1 Alberto Rolim Muro Martinez  15 Sandra Cristina Gonçalves Martinez  24 Saulo Nardy Nader  1 Luciana de Oliveira Neves  25 Ivan Hideyo Okamoto  19 Rogério Adas Ayres de Oliveira  1 Fabiano de Melo Peixoto  1 Cristiana Borges Pereira  1 Roberta Arb Saba  26   27 Leticia Pereira de Brito Sampaio  1 Lucas Porcello Schilling  28 Marcus Tulius Teixeira Silva  29 Emanuelle Roberta Silva  1   3 Jerusa Smid  1 Cristiane Nascimento Soares  23 Manoel Sobreira-Neto  30 Nise Alessandra de Carvalho Sousa  31 Leonardo Cruz de Souza  32 Hélio Afonso Ghizoni Teive  33 Vera Cristina Terra  34 Matheus Vale  18 Vitor Mendes Grise Vieira  18 Edmar Zanoteli  1   35 Gilmar Prado  26
Affiliations

Cannabinoids in Neurology - Position paper from Scientific Departments from Brazilian Academy of Neurology

Sonia Maria Dozzi Brucki et al. Arq Neuropsiquiatr. 2021 Apr.

Abstract

Cannabinoids comprehend endocannabinoids, phytocannabinoids, and synthetic cannabinoids, with actions both in the central and peripherical nervous systems. A considerable amount of publications have been made in recent years, although cannabis has been known for over a thousand years. Scientific Departments from the Brazilian Academy of Neurology described evidence for medical use in their areas. Literature is constantly changing, and possible new evidence can emerge in the next days or months. Prescription of these substances must be discussed with patients and their families, with knowledge about adverse events and their efficacy.

Os canabinoides compreendem os endocanabinoides, fitocanabinoides e os canabinoides sintéticos e desempenham ações no sistema nervoso central e periférico. Uma quantidade enorme de publicações tem sido lançada nos últimos anos, embora a cannabis seja conhecida por milênios. Os Departamentos Científicos da Academia Brasileira de Neurologia descreveram as evidências do uso médico em suas áreas. A literatura está em constantes mudanças e possíveis novas evidências podem surgir nos próximos dias ou meses. A prescrição dessas substâncias deve ser discutida com os pacientes e suas famílias, com conhecimento sobre eventos adversos e sua eficácia.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors do not have conflict of interests, except for Dr. Renato Anghinah who is director in HempMeds.

References

    1. 1. Campos AC, Fogaça MV, Sonego AB, Guimarães FS. Cannabidiol, neuroprotection and neuropsychiatric disorders. Pharmacol Res. 2016 Oct;112:119-27. https://doi.org/10.1016/j.phrs.2016.01.033 - PubMed
    1. 2. Cristino L, Bisogno T, Di Marzo V. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol. 2020 Jan;16(1):9-29. https://doi.org/10.1038/s41582-019-0284-z - PubMed
    1. 3. Noel C. Evidence for the use of ‘‘medical marijuana’’ in psychiatric and neurologic disorders. Ment Health Clin. 2017 Jan;7(1):29-38. https://doi.org/10.9740/mhc.2017.01.029 - PMC - PubMed
    1. 4. Bennaroch EE. Synaptic effects of cannabinoids: complexity, behavioral effects and potential clinical implications. Neurology. 2014 Nov;83(21):1958-67. https://doi.org/10.1212/WNL.0000000000001013 - PubMed
    1. 5. Giacoppo S, Mandolino G, Galuppo M, Bramanti P, Mazzon E. Cannabinoids: new promising agents in the treatment of neurological diseases. Molecules. 2014 Nov;19(11):18781-816. https://doi.org/10.3390/molecules191118781 - PMC - PubMed